Victo™可调节人工尿道括约肌治疗男性尿失禁的结局
本研究纳入96例前列腺术后重度尿失禁患者,接受Victo™可调节人工尿道括约肌植入,中位随访3年。24小时尿垫试验在3个月时中位降低83%、3年时中位降低79%(均P<0.001),患者满意度在中期随访中较高,随访期间器械故障13例(14%)。
要点
- 前列腺术后尿失禁患者植入Victo™后24小时尿垫试验3个月中位降低83%、3年中位降低79%(均P<0.001)。
- PGI-I评为「非常改善」「明显改善」或「轻微改善」的患者比例在3个月、1年、2年、3年、4年、5年分别为87%、92%、87%、81%、83%、50%(5/10)。
- 随访期间器械故障共13例(14%)。
核心结论
- 数据提示Victo™可显著降低前列腺术后尿失禁的严重程度,并在中期随访中提供较高的患者自报治疗满意度。
研究设计与样本
- 本研究为前瞻性评估队列,纳入2018年5月至2023年12月期间因前列腺术后尿失禁接受Victo™植入的患者,最终分析96例,中位年龄68岁(IQR 65-72),中位随访3年(IQR 1-4),其中10例完成5年随访。
主要发现
- 治疗后24小时尿垫试验中位降低83%(P<0.001)在3个月时,中位降低79%(P<0.001)在3年时。
- PGI-I评为「非常改善」「明显改善」或「轻微改善」的患者比例在3个月为87%、1年为92%、2年为87%、3年为81%、4年为83%、5年为50%(5/10)。
- 对治疗结果「非常满意」或「满意」的患者比例在3个月为79%、1年为80%、2年为75%、3年为69%、4年为80%、5年为60%(6/10)。
- 随访期间器械故障共13例(14%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To report the clinical outcomes of the Victo™ (Promedon, Cordoba, Argentina) adjustable artificial urinary sphincter (AUS) implantation in a cohort of patients with severe urinary incontinence (UI) after prostate surgery. PATIENTS AND METHODS: This study enrolled patients with UI following prostate surgery who underwent a Victo implantation between May 2018 and December 2023. Patients were prospectively evaluated at baseline, and at 3 and 12 months after device activation, and thereafter annually. The 24-h pad-weight test (24hPWT) was used to assess severity of UI, while the Patient Global Impression of Improvement (PGI-I) and patient satisfaction according to a Likert scale were used to measure patient-reported outcomes. RESULTS: A total of 96 patients with a median (interquartile range [IQR]) age of 68 (65-72) years were included in the final analysis. The median (IQR) follow-up was 3 (1-4) years. In all, 10 patients completed the 5-year follow-up. After the treatment, we observed a significant reduction in 24hPWT by the median of 83% (P < 0.001) at 3 months and by a median of 79% (P < 0.001) at 3 years. According to the PGI-I, a total of 87%, 92%, 87%, 81%, 83%, and 50% (five of 10) of patients rated their condition/incontinence as 'very much improved', 'much improved' or 'little improved' at 3 months, 1-, 2-, 3-, 4-, and 5-year follow-up visits, respectively. The proportion of patients, who were 'very satisfied' or 'satisfied' with the treatment outcome was 79%, 80%, 75%, 69%, 80%, and 60% (six of 10) at 3 months, 1-, 2-, 3-, 4-, and 5-years, respectively. There were a total of 13 (14%) device failures during the follow-up period. CONCLUSION: In conclusion, our data suggest that Victo AUS significantly reduces the severity of UI after prostate surgery and provides a reasonably high patient-reported satisfaction with treatment outcomes at mid-term follow-up.
引用
- Krhut J, Bartáková L, Kondé A, et al. Outcomes of the Victo™ adjustable artificial urinary sphincter in the treatment of male incontinence. BJU Int. 2024. PMID: 39187277. doi:10.1111/bju.16511
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。